Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments.

Niemann-Pick type C (NPC) disease is characterized by an accumulation of cholesterol and other lipids in the lysosomal compartment. In this report, we use subcellular fractionation and microscopy to determine the localization of the murine Niemann-Pick C1 (NPC1) protein. Fractionation of mouse liver homogenates indicates that some NPC1 cosediments with lysosome-associated membrane protein 1 (LAMP1)-containing membranes. However, a significant amount of NPC1 is also found in membranes that do not contain LAMP1. Moreover, fractionation of liver membranes and fibroblasts in the presence of a nonionic detergent showed that a fraction of NPC1 cosediments with caveolin-1 in rafts. Immunofluorescence microscopy of cultured mouse fibroblasts showed that NPC1 is found in two morphologically distinct structures. The first population is characterized by large punctate structures that do not colocalize with major organelle protein markers, but do colocalize with filipin and a small fraction of caveolin-1. Examination of these large NPC1-containing compartments using electron microscopy shows that these structures contain extensive internal membranes. The second population is represented by smaller, more diffuse structures, a fraction of which colocalize with LAMP1-positive compartments. Incubation of fibroblasts with low density lipoprotein (LDL) increases colocalization of NPC1 with LAMP1-containing compartments. This colocalization can be further enhanced by treating fibroblasts with progesterone or chloroquine. The results indicate that NPC1 is associated with an unique vesicular compartment enriched with cholesterol and containing caveolin-1, and that NPC1 cycles to LAMP1-positive compartments, presumably to facilitate the processing of LDL-derived cholesterol.

[1]  Y. Ioannou,et al.  Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. , 1999, Molecular genetics and metabolism.

[2]  J. Hancock,et al.  Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains , 1999, Nature Cell Biology.

[3]  M. Patterson,et al.  The Niemann-Pick C1 Protein Resides in a Vesicular Compartment Linked to Retrograde Transport of Multiple Lysosomal Cargo* , 1999, The Journal of Biological Chemistry.

[4]  R. Heidenreich,et al.  The Npc1 mutation causes an altered expression of caveolin-1, annexin II and protein kinases and phosphorylation of caveolin-1 and annexin II in murine livers. , 1999, Biochimica et biophysica acta.

[5]  R. Brady,et al.  Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Watari,et al.  Niemann-Pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Richard G. W. Anderson,et al.  Cholesterol Depletion of Caveolae Causes Hyperactivation of Extracellular Signal-related Kinase (ERK)* , 1998, The Journal of Biological Chemistry.

[8]  T. Steck,et al.  Circulation of Cholesterol between Lysosomes and the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[9]  P. Beachy,et al.  Teratogen-mediated inhibition of target tissue response to Shh signaling. , 1998, Science.

[10]  Y. Ying,et al.  Characterization of a Cytosolic Heat-shock Protein-Caveolin Chaperone Complex , 1998, The Journal of Biological Chemistry.

[11]  K. Nakashima,et al.  Increased levels of GM2 ganglioside in fibroblasts from a patient with juvenile Niemann–Pick disease type C , 1998, Brain and Development.

[12]  L. Liscum,et al.  Evidence for a Cholesterol Transport Pathway from Lysosomes to Endoplasmic Reticulum That Is Independent of the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[13]  T. Katsumoto,et al.  Accumulation of cholesterol and GM2 ganglioside in cells cultured in the presence of progesterone: an implication for the basic defect in Niemann-Pick disease type C , 1998, Brain and Development.

[14]  M. Lohse,et al.  A dileucine motif in the C terminus of the beta2-adrenergic receptor is involved in receptor internalization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Parton,et al.  Regulation of caveolin and caveolae by cholesterol in MDCK cells. , 1997, Journal of lipid research.

[16]  R. Erickson,et al.  Altered expression of caveolin-1 and increased cholesterol in detergent insoluble membrane fractions from liver in mice with Niemann-Pick disease type C. , 1997, Biochimica et biophysica acta.

[17]  J. Tomasek,et al.  Internalized plasma membrane cholesterol passes through an endosome compartment that is distinct from the acid vesicle-lysosome compartment. , 1997, Experimental cell research.

[18]  W. Pavan,et al.  Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. , 1997, Science.

[19]  K. G. Coleman,et al.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.

[20]  J. Chin,et al.  The Fate of Cholesterol Exiting Lysosomes* , 1997, The Journal of Biological Chemistry.

[21]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[22]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[23]  A. Bist,et al.  Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Germain,et al.  Related Leucine-based Cytoplasmic Targeting Signals in Invariant Chain and Major Histocompatibility Complex Class II Molecules Control Endocytic Presentation of Distinct Determinants in a Single Protein , 1997, The Journal of experimental medicine.

[25]  A. Mendez,et al.  Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. , 1996, Journal of lipid research.

[26]  Richard G. W. Anderson,et al.  A Role for Caveolin in Transport of Cholesterol from Endoplasmic Reticulum to Plasma Membrane* , 1996, The Journal of Biological Chemistry.

[27]  J. Pitha,et al.  Intracellular Trafficking of Cholesterol Monitored with a Cyclodextrin* , 1996, The Journal of Biological Chemistry.

[28]  C. Fielding,et al.  Plasma membrane caveolae mediate the efflux of cellular free cholesterol. , 1995, Biochemistry.

[29]  F. Wieland,et al.  VIP21/caveolin is a cholesterol-binding protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Liscum,et al.  Intracellular Cholesterol Transport and Compartmentation (*) , 1995, The Journal of Biological Chemistry.

[31]  A. Mendez.  Monensin and Brefeldin A Inhibit High Density Lipoprotein- mediated Cholesterol Efflux from Cholesterol-enriched Cells , 1995, The Journal of Biological Chemistry.

[32]  P. Conrad,et al.  Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation , 1994, The Journal of cell biology.

[33]  T. Steck,et al.  Cholesterol homeostasis. Modulation by amphiphiles. , 1994, The Journal of biological chemistry.

[34]  R. F. Cook,et al.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease , 1994, The Journal of cell biology.

[35]  P. Dupree,et al.  VIP21‐Caveolin, a protein of the trans‐Golgi network and caveolae , 1994, FEBS letters.

[36]  C. Zurzolo,et al.  VIP21/caveolin, glycosphingolipid clusters and the sorting of glycosylphosphatidylinositol‐anchored proteins in epithelial cells. , 1994, The EMBO journal.

[37]  P. Pentchev,et al.  Differential accumulation of cholesterol in Golgi compartments of normal and Niemann-Pick type C fibroblasts incubated with LDL: a cytochemical freeze-fracture study. , 1993, Journal of lipid research.

[38]  T. Koeda,et al.  Type C Niemann-Pick disease Detection and quantification of cholesterol-accumulating cells in bone marrow , 1993, Brain and Development.

[39]  G. Raposo,et al.  Caveolae and sorting in the trans‐Golgi network of epithelial cells. , 1993, The EMBO journal.

[40]  M. Patterson,et al.  Progesterone blocks cholesterol translocation from lysosomes. , 1992, The Journal of biological chemistry.

[41]  D. Rickwood,et al.  Isolation of the major subcellular organelles from mouse liver using Nycodenz gradients without the use of an ultracentrifuge. , 1990, Analytical biochemistry.

[42]  W. J. Johnson,et al.  The efflux of lysosomal cholesterol from cells. , 1990, The Journal of biological chemistry.

[43]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[44]  L. Liscum,et al.  The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. , 1989, The Journal of biological chemistry.

[45]  R. Brady,et al.  Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Liscum,et al.  Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts. , 1987, The Journal of biological chemistry.

[47]  R. Brady,et al.  Group C Niemann‐Pick disease: faulty regulation of low‐density lipoprotein uptake and cholesterol storage in cultured fibroblasts , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  S. Patel,et al.  Type C Niemann-Pick disease. A parallel loss of regulatory responses in both the uptake and esterification of low density lipoprotein-derived cholesterol in cultured fibroblasts. , 1986, The Journal of biological chemistry.

[49]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[50]  R. Brady,et al.  A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[51]  K. Suckling,et al.  Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. , 1985, Journal of lipid research.

[52]  R. Brady,et al.  A genetic storage disorder in BALB/C mice with a metabolic block in esterification of exogenous cholesterol. , 1984, The Journal of biological chemistry.

[53]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Goldstein,et al.  Regulation of the activity of the low density lipoprotein receptor in human fibroblasts , 1975, Cell.

[55]  M. Brown,et al.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[56]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[57]  P. Beachy,et al.  Multiple roles of cholesterol in hedgehog protein biogenesis and signaling. , 1997, Cold Spring Harbor symposia on quantitative biology.

[58]  A. Attie,et al.  Rapid intracellular transport of LDL-derived cholesterol to the plasma membrane in cultured fibroblasts. , 1990, Journal of lipid research.

[59]  J. Oram.  Receptor-mediated transport of cholesterol between cultured cells and high-density lipoproteins. , 1986, Methods in enzymology.